A number of different approaches have been utilized in recent years for the treatment of Parkinson's disease with varying effects on associated communication disorders. In particular, the drug treatments based on levodopa therapy and, more recently, deep brain stimulation of the subthalamic nucleus (STN-DBS) have yielded variable effects on the speech disorders exhibited by the majority of persons with Parkinson's disease. With respect to STN-DBS, although reports indicate significant improvement in the symptomatology in Parkinson's disease associated with limb function, the majority of reports suggest that the procedure has either minimal or, in most cases, negative effects on speech abilities of the affected individuals. By far the most effective speech therapy technique applied to dysarthria in Parkinson's disease reported to date is the Lee Silverman Voice Treatment (LSVT) program. In addition to speech impairment, in recent years there has also been increasing awareness that Parkinson's disease is also associated with the occurrence of language disorders, especially in its later stages. This special issue contains 13 papers of which 10 are related to issues associated with speech impairment and 3 further papers explore aspects of language impairment in Parkinson's disease. on articulation rate and quality of plosive consonants in two articulatory diadochokinetic tasks. Whereas patients receiving STN-DBS increased in articulation rate with no effect on production quality, patients receiving cZi-DBS decreased in articulation rate and further showed reduction in production quality suggesting that cZi-DBS is more detrimental for extended articulatory movements than STN-DBS.
The third Although the results showed significant improvement in loudness and intonation after treatment, no significant changes were reported in lexical tone. The sixth paper included in the special issue, "Acoustic analysis of PD speech" by K. Chenausky et al. investigated speech changes as a result of STN-DBS settings chosen to maximize motor performance. Importantly, clinically motivated settings evaluated by the researchers showed a greater capacity to impair, rather than improve, speech. Lingual kinematics during consonant production in both dysarthric and nondysarthric speakers with Parkinson's disease were investigated in the seventh paper, "Lingual kinematics in dysarthric and nondysarthric speakers with Parkinson's disease" by M. N. Wong et al. The findings indicated that dysarthric and nondysarthric speakers with Parkinson's disease had deviant articulatory movement during consonant production that results in longer duration of consonant production. Importantly, these findings are contrary to contemporary theories that suggest articulatory imprecision in dysarthric speakers with Parkinson's disease is an outcome of reduced range of articulatory movement.
The eighth paper in the current issue, "Assessment of prosodic communicative efficiency in Parkinson's disease as judged by professional listeners" by H. Martens et al. investigated the impact of Parkinson's disease on communicative efficiency conveyed through prosody. Although no significant differences were found for emotional prosody, patients with a moderate or severe dysarthria performed significantly worse on imitation of Focus than on reading of Focus. The ninth paper included in the special issue, "Perception of speech by individuals with Parkinson's disease: a review" by L. C. Kwan and T. L. Whitehill, explored the possibility of the presence of a deficit in the perception of speech in individuals with Parkinson's disease. Based on a review of the literature, it was concluded that Parkinson's disease specifically impairs patients' perception of verbal emotions. The aim of the tenth paper, "A cognitive-perceptual approach to conceptualizing speech intelligibility deficits and remediation practice in hypokinetic dysarthria" by K. L. Landsford et al. was to introduce a novel framework for medical practitioners in order to conceptualize and justify potential targets for speech remediation in patients with Parkinson's disease. The most commonly targeted deficits, including speaking rate and vocal loudness, were supported by this approach.
The eleventh paper, "High-level language production in Parkinson's disease: a review" by L. J. P. Altmann and M. S. Troche, reviewed the literature on language production in Parkinson's disease and provided detailed discussion of the language production processes that are impaired in this condition. It was concluded that Parkinson's disease affects all stages of language production, including conceptualization, functional and positional processing. Two semantic priming tasks designed to isolate automatic and controlled semantic activation were utilized in the twelfth paper, "The influence of dopamine on automatic and controlled semantic activation in Parkinson's disease" by W. L. Arnott et al. to investigate the impact of dopamine depletion on semantic processing in Parkinson's disease. Overall, the results demonstrated that dopamine depletion can cause disturbances in both automatic and controlled semantic activation. The final paper in this special issue, "Sentence comprehension and its association with executive functions in patients with Parkinson's disease" by K. S. F. Colman et al. aimed to provide insight into the interaction between linguistic representation and processing and executive functioning in individuals with Parkinson's disease. Overall, it was concluded that there does not appear to be a language faculty independent of executive functioning.
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